These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 33560097

  • 41. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C, Venet C, Jehl F, Mwewa S, Lazarevic V, Diconne E, Fonsale N, Carricajo A, Guyomarc'h S, Vermesch R, Aubert G, Bidault R, Bertrand JC, Zeni F.
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
    Malone RS, Fish DN, Abraham E, Teitelbaum I.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
    [Abstract] [Full Text] [Related]

  • 45. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
    Ikawa K, Morikawa N, Ikeda K, Suyama H.
    J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF).
    Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Tonetti T, Giannella M, Viale P, Pea F.
    J Crit Care; 2023 Aug; 76():154301. PubMed ID: 37059003
    [Abstract] [Full Text] [Related]

  • 48. An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy.
    Sember AM, LoFaso ME, Lewis SJ.
    J Crit Care; 2022 Jun; 69():154011. PubMed ID: 35202996
    [Abstract] [Full Text] [Related]

  • 49. Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Peng Y, Cheng Z, Xie F.
    Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0082222. PubMed ID: 36005753
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A, Luque S, Grau S, Agrifoglio A, Cachafeiro L, Herrero E, Asensio MJ, Sánchez SM, Roberts JA.
    Antimicrob Agents Chemother; 2016 Oct 20; 60(10):5914-21. PubMed ID: 27458229
    [Abstract] [Full Text] [Related]

  • 54. Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations.
    Morimatsu H, Uchino S, Bellomo R, Ronco C.
    Int J Artif Organs; 2002 Jun 20; 25(6):512-9. PubMed ID: 12117290
    [Abstract] [Full Text] [Related]

  • 55. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP, Kielstein JT, Czock D, Xie J, Field J, Richards B, Tallott M, Visser A, Koenig C, Hafer C, Schmidt JJ, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2018 Aug 20; 52(2):151-157. PubMed ID: 29526606
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.